These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8985663)

  • 21. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
    McLinn S; Williams D
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the EUCAST disc diffusion susceptibility testing method for Haemophilus influenzae based on the resistance mechanism to β-lactam antibiotics.
    García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Oteo J; Campos J
    J Antimicrob Chemother; 2013 Jan; 68(1):159-63. PubMed ID: 23034712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
    Billal DS; Hotomi M; Yamanaka N
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
    [No Abstract]   [Full Text] [Related]  

  • 24. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM; Suter M; Borsos S
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
    Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
    J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae from other H. influenzae strains by a disc method.
    Ubukata K; Chiba N; Hasegawa K; Shibasaki Y; Sunakawa K; Nonoyama M; Iwata S; Konno M
    J Infect Chemother; 2002 Mar; 8(1):50-8. PubMed ID: 11957120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
    Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beta lactam resistance and molecular markers of 157 Haemophilus influenzae isolates from infants in Tunis].
    Oueslati S; Smaoui H; Joubert G; Dabernat H; Kechrid A
    Can J Microbiol; 2009 May; 55(5):515-9. PubMed ID: 19483779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV; Vautour R
    Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1992; 38(1):7-13. PubMed ID: 1618006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
    Anderson EL; Robinson PA; Tu KK; Adams CR
    South Med J; 1985 Jun; 78(6):643-6. PubMed ID: 3873708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of N526K-substituted penicillin-binding protein 3 conferring low-level mutational resistance to β-lactam antibiotics in Haemophilus influenzae by disc diffusion testing on Mueller-Hinton agar according to EUCAST guidelines.
    Søndergaard A; Petersen MT; Fuursted K; Nørskov-Lauritsen N
    J Antimicrob Chemother; 2012 Jun; 67(6):1401-4. PubMed ID: 22389455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
    Powell M; McVey D; Kassim MH; Chen HY; Williams JD
    J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD; Powell M; Fah YS; Seymour A; Yuan M
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
    Piot P; Van Dyck E
    Antimicrob Agents Chemother; 1982 Jan; 21(1):166-7. PubMed ID: 6805422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000.
    Koeth LM; Felmingham D; Jacobs MR; Rossi F
    Int J Antimicrob Agents; 2004 Apr; 23(4):356-61. PubMed ID: 15081084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].
    Fenoll A; Robledo O; Lerma M; Giménez MJ; Cebrián L; Casal J; Aguilar L; Gómez-Lus ML
    Rev Esp Quimioter; 2006 Mar; 19(1):39-44. PubMed ID: 16688290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.